| Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide.
In a mid-stage clinical trial, the experimental drug retaglutide helped people lose an average of about 24% of their body weight, equivalent to about 58 pounds. The findings were simultaneously published in the New England Journal of Medicine. It can provide more weight loss than any drug currently on the market. Retatrutide could leapfrog another weight loss drug, tirzepatide, which experts estimated earlier this year could become the best-selling drug of all time. Whatsapp:+86 19933155940 |
